Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses (Q35485247)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses |
scientific article |
Statements
1 reference
Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses (English)
1 reference
Joshua Pink
1 reference
Steven Lane
1 reference
31 October 2011
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference